Dabur Pharmaceutical Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24231DL1985PLC021308 Incorporated 25 June 1985 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma
Authorised capital
₹2.1 Cr
Registered with MCA
Paid-up capital
₹1.96 Cr
Issued & subscribed
Company age
41 yrs
Est. 1985
Directors on board
3
As per MCA filings
Brands
1
Associated brands
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data

About Dabur Pharmaceutical Ltd

Data last updated:

Dabur Pharmaceutical Ltd is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 June 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1985PLC021308.

The company has an authorised share capital of ₹2.1 Cr and a paid-up capital of ₹1.96 Cr. It was formerly known as Key Pharmaceuticals Pvt Ltd and Key Pharmaceuticals Ltd. It is led by directors including Gaurav Chamaria and Akhil Mahajan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002.

The company is associated with 1 brand: Dabur. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹1.8 Cr; the latest was in September 2016.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231DL1985PLC021308
Registration Number 021308
Incorporation Date 25 June 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Name history

Dabur Pharmaceutical has undergone 2 name changes throughout its history. The company was previously known as Key Pharmaceuticals Pvt Ltd, and Key Pharmaceuticals Ltd. The current legal name is Dabur Pharmaceutical Ltd.

Company NameStatus
Dabur Pharmaceutical LtdCurrent
Key Pharmaceuticals Pvt LtdPrevious
Key Pharmaceuticals LtdPrevious

Contact details

Dabur Pharmaceutical Ltd's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1st Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Dabur Pharmaceutical Ltd, buy the company report.

Comprehensive company report
Dabur Pharmaceutical Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dabur Pharmaceutical operates one associated brand: Dabur. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of ayurvedic medicine and natural consumer productsdabur.com

Financials of Dabur Pharmaceutical Ltd

FY 2024 filings available

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dabur Pharmaceutical Ltd, buy the company report.

Board of directors of Dabur Pharmaceutical Ltd

Dabur Pharmaceutical has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gaurav ChamariaDirector15 May 20251 Years 6 MonthsCurrent
Ram Prakash SharmaAdditional Director10 Nov 20251 Years 0 MonthsCurrent
Akhil MahajanDirector23 Jan 20242 Years 9 MonthsCurrent

Auditor

Dabur Pharmaceutical Ltd is audited by JHALANI & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
JHALANI & COFY 2023003675N

Shareholding

The shareholding of Dabur Pharmaceutical Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dabur Pharmaceutical Ltd, buy the company report.

Deals & funding

Dabur Pharmaceutical Ltd has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹1.8 Cr; the latest was in September 2016.

Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹1.8 Cr

Deals on record (3 of 4)

WhenDealAmountParties
Sep 2016Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2015Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Sep 2014Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Dabur Pharmaceutical Ltd, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dabur Pharmaceutical Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Dabur Pharmaceutical Ltd; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Dabur Pharmaceutical Ltd has 14 board changes on record since 2009: 3 appointments and 11 cessations. The latest: Ram Prakash Sharma was appointed as Additional Director on 10 Nov 2025.

Appointed
Ram Prakash Sharma was appointed as Additional Director.
Ceased
Gaurav Chamaria ceased to be Additional Director.
Appointed
Gaurav Chamaria was appointed as Director.
AGM
Dabur Pharmaceutical Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Akhil Mahajan ceased to be Additional Director.
Filing
Dabur Pharmaceutical Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Akhil Mahajan was appointed as Director.
Ceased
Pankaj Bhardwaj ceased to be Additional Director.
Ceased
Rakesh Malhotra ceased to be Director.
Ceased
Anurag Gupta ceased to be Additional Director.
Ceased
Anand Chand Burman ceased to be Director.
Ceased
Mohit Burman ceased to be Director.

5 earlier events are in the company report.

Frequently asked questions

Dabur Pharmaceutical is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 June 1985 (41+ years old) and is registered under CIN U24231DL1985PLC021308.

Dabur Pharmaceutical has 3 current directors:

The latest financial statements of Dabur Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Dabur Pharmaceutical is U24231DL1985PLC021308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dabur Pharmaceutical was incorporated on 25 June 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.

Dabur Pharmaceutical has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹1.8 Cr; the latest was in September 2016.

Ram Prakash Sharma was appointed as Additional Director on 10 Nov 2025. Gaurav Chamaria ceased to be Additional Director on 29 Sep 2025. Gaurav Chamaria was appointed as Director on 15 May 2025. Dabur Pharmaceutical has 14 board changes on record in total.

The registered office of Dabur Pharmaceutical is at 1st Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002.

Dabur Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Dabur Pharmaceutical is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.